宜宾埋线双眼皮好医院宜宾做双眼皮最好的是哪家医院,宜宾眼睛上睑下垂,宜宾隆鼻特价,宜宾乳房假体隆胸,宜宾市专业双眼皮手术副作用,宜宾哪家切双眼皮医院较好,宜宾隆胸假体取出后感受

SAN FRANCISCO, Dec. 29 (Xinhua) -- The United States Patent and Trademark Office on Thursday published a patent application from Apple related to face and presence detection for iOS devices, which is expected to be one of the next chapters for mobile security.According to AppleInsider, a news and rumor website focusing on Apple, the patent is entitled "low threshold face recognition" which is a low-computation solution for quickly and accurately recognizing a user on iPhone, iPad, iPod Touch and MacBook.Patently Apple, a blog focusing on Apple's latest intellectual properties, said that iOS devices would acknowledge the presence of the potential user by turning on the display and then trigger a subsequent process for recognizing the potential user's face.Currently, most face recognition systems tend to be robust ones working in various lighting conditions, orientations, scale and etc., which will require computing resources and drain battery life. There are also security-type face recognition systems working under controlled lighting conditions which could be ineffective due to factors like proximity of the user to the camera.Google's latest Android 4.0 operating system, codenamed Ice Cream Sandwich, already features face detection. But it is reported that the feature doesn't always work and can be bypassed by using a photograph of the phone's owner.Apple's solution would reduce the impact of lighting conditions and biometric distortions on an image, said AppleInsider, citing the filing. Apple said it would rely on a "high information portion" of a human face, such as eyes, mouth or the tip of a user 's nose.The "likely presence" of a human face in front of the camera would be captured through an "orange-distance filter" which would also be used to detect the potential user's skin tone and measure the distance of their face from the camera.Meanwhile, iOS devices could also be set to recognize faces of multiple users, presenting each user with a personalized configuration.According to AppleInsider, the patent application was first filed by Apple in June, 2009.Analysts said that the proposed technology could be Apple's next big innovation as it has record of redesign and give its unique appeal to products that have not caught on with the general public.

BEIJING, Jan. 24 (Xinhua) -- Chinese President Hu Jintao and Premier Wen Jiabao on Tuesday exchanged congratulatory messages with their Israeli counterparts Shimon Peres and Benjamin Netanyahu on the 20th anniversary of the establishment of diplomatic ties between the two countries.Hu said the friendly exchanges between the Chinese and the Jewish people go back to ancient times.Since the forging of official ties 20 years ago, friendly cooperative ties between China and Israel have been developing continuously, and the exchanges and cooperation between the two sides in politics, economy and trade, culture, science and technology, agriculture and education have yielded fruitful results and brought tangible benefits to the two countries and the two peoples, Hu said.China attaches great importance to advancing Sino-Israeli ties and is ready to make joint efforts with Israel to take the celebration of the 20th anniversary as an opportunity to further consolidate the traditional Sino-Israeli friendship, deepen mutual cooperation in various fields, increase personnel exchanges on multiple levels, and promote a continuous development of friendly Sino-Israeli cooperative relations, he said.For his part, Peres said Israel and China established official diplomatic ties 20 years ago, which brought the friendship between the two countries to a historic high.He believed that the Israeli-Chinese friendship, which is based on a shared history, common values and ancient culture and tradition, will prevail.Peres said his country pays great attention to its ties with China in all areas, and is willing to conduct mutually beneficial cooperation with China in science and technology and other fields.In his message, Peres wished the Chinese people a "Happy New Year" in the Year of the Dragon.On the same day, Chinese Premier Wen also exchanged congratulatory messages with Israeli Prime Minister Netanyahu.Wen said their bilateral friendly cooperative relations have continued to grow over the last 20 years.Political exchanges between the two countries have been increasingly close, economic and trade cooperation have continued to flourish, and pragmatic cooperation in culture, science and technology, and agriculture has been fruitful, Wen said.China and Israel have their own advantages, as well as huge potential and broad prospects for cooperation, the Chinese premier said.China is ready to continue to expand and deepen its friendly bilateral cooperation with Israel and raise Sino-Israeli ties to a new high, Wen said.For his part, Netanyahu said the Chinese and the Jewish people have always been friends.During the past 20 years, China and Israel succeeded in forging a stable and diversified partnership, he said.The Israeli side is ready to fully explore the potential of bilateral ties and continue to expand cooperation in science and technology, sanitation, agriculture and environmental protection technologies and other fields with China, Netanyahu said.He believed that there will be more opportunities to further consolidate the friendship between the two peoples and deepen bilateral cooperation in the future.Chinese Foreign Minister Yang Jiechi and Israeli Foreign Minister Avigdor Lieberman also exchanged congratulatory messages.

WASHINGTON, Oct. 3 (Xinhua) -- Researchers at St. Michael's Hospital in Canada have discovered a new function for an enzyme that may protect against organ injury and death from anemia, according to a study appearing Monday in the U.S. journal of the Proceeding of the National Academy of Sciences.Researchers found that when people have anemia, neuronal nitric oxide synthase (nNOS) -- an enzyme in nerve cells that produces nitric oxide, an important signaling molecule in the body -- increases the body's ability to respond, adapt to low oxygen levels and makes the body more efficient in delivering oxygen to tissues. They also found that levels of nNOS in the brain increased in anemic mice, and that the mice without this enzyme die earlier, and with higher hemoglobin levels."Identifying this mechanism may lead to new therapies and approaches to improving outcomes for anemic patients," said Dr. Greg Hare, a researcher at the Li Ka Shing Knowledge Institute of the hospital and one of the lead investigators of the study.Anemia occurs when blood has a lower than normal number of red blood cells or hemoglobin -- an iron-rich protein that carries oxygen from the lungs and heart to the rest of the body. Cells need oxygen to survive and to produce energy for all bodily functions. The condition has many different causes including infection (malaria, HIV, parasites), nutritional deficiencies (iron, folate, B12), genetic mutations, pregnancy, trauma and surgical blood loss."This research will help us identify when an anemic patient is at greatest risk for injury and death when undergoing surgery," said Hare. "Research is underway to test these findings in humans."

WASHINGTON, Nov. 24 (Xinhua) -- An inexpensive drug that treats Type 2 diabetes has been shown to prevent a number of natural and man-made chemicals from stimulating the growth of breast cancer cells, according to a newly published study by a Michigan State University researcher. The research, led by pediatrics professor James Trosko and colleagues from South Korea's Seoul National University, provides biological evidence for previously reported epidemiological surveys that long-term use of the drug metformin for Type 2 diabetes reduces the risk of diabetes-associated cancers, such as breast cancers.The research appeared online this week in PLoS One.For the study, Trosko and colleagues focused on the concept that cancers originate from adult human stem cells and that there are many natural and man-made chemicals that enhance the growth of breast cancer cells. Using culture dishes, they grew miniature human breast tumors, or mammospheres, that activated a certain stem cell gene. Then the mammospheres were exposed to natural estrogen -- a known growth factor and potential breast tumor promoter -- and man-made chemicals that are known to promote tumors or disrupt the endocrine system.The team found that estrogen and the chemicals caused the mammospheres to increase in numbers and size. However, with metformin added, the numbers and size of the mammospheres were dramatically reduced. While each of the chemicals enhanced growth by different means, metformin seemed to be able to inhibit their stimulated growth in all cases."While future studies are needed to understand the exact mechanism by which metformin works to reduce the growth of breast cancers, this study reveals the need to determine if the drug might be used as a preventive drug and for individuals who have no indication of any existing cancers," Trosko said.